Records containing: Severe Preeclampsia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Assessment of the Association Between Predefined Factors and Response or Failure of Blood Pressure Control With Intravenous Labetalol Monotherapy in Severe Preeclampsia: a Multicenter Observational Study
-
CLINICAL_TRIALS study record update · 2025-12-04Comparison of Base Excess in Arterial Blood Gases Between Patients With Severe Preeclampsia and Normotensive Pregnant Patients
-
CLINICAL_TRIALS study record update · 2025-10-24Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial "LEVMag Trial"
-
CLINICAL_TRIALS study record update · 2025-09-24Diastolic Dysfunction in the Pregnant Woman With Preeclampsia
-
CLINICAL_TRIALS study record update · 2025-08-27The Association Between Clinical, Laboratory and Ultrasonographic Findings With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-03ALTERNATE DOSING PROTOCOL FOR MAGNESIUM SULFATE IN OVERWEIGHT AND OBESE WOMEN WITH PREECLAMPISA: A RANDOMIZED CONTROLLED TRIAL
-
CLINICAL_TRIALS study record update · 2024-02-20A Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine to Control Blood Pressure in Severe Pre-eclampsia
-
CLINICAL_TRIALS study record update · 2023-11-29Complement Regulation to Undo Systemic Harm in Preeclampsia: The CRUSH Study
-
CLINICAL_TRIALS study record update · 2022-04-04A Phase 2b/3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia
-
CLINICAL_TRIALS study record update · 2021-09-10Statistical Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Severe Preeclampsia in a Low-resource Setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.
-
CLINICAL_TRIALS study record update · 2020-04-24Efficacy and Safety of One Gram Versus Two Grams Intravenous Maintenance Dose of Magnesium Sulfate in Women With Severe Pre-eclampsia: a Randomized Clinical Trial.
-
CLINICAL_TRIALS study record update · 2019-07-23First-trimester Prediction of Preeclampsia and Other Placenta-mediated Pregnancy Complications
-
CLINICAL_TRIALS study record update · 2019-07-23Pré-Eclampsie et Retard de Croissance: Une étude Longitudinale Évaluative (PERLE)
-
CLINICAL_TRIALS study record update · 2018-11-20Serum Androgen Levels as a Marker for the Severity of Preeclampsia
-
CLINICAL_TRIALS study record update · 2018-01-04Association Between Restless Leg Syndrome and Severe Preeclampsia. A Case Control Study.
-
CLINICAL_TRIALS study record update · 2015-01-05Antiphospholipid Antibodies and Early Severe Preeclampsia (< 34 Weeks of Gestation). A Case-Control Study.
-
CLINICAL_TRIALS study record update · 2015-01-05Carbetocin Versus Oxytocin for Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia: a Double Blind Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2013-08-06ClinicalTrials.gov study NCT01906567
-
CLINICAL_TRIALS study record update · 2012-08-22Postpartum Prophylaxis With Short Course Magnesium Sulfate in Severe Preeclampsia: a Randomized Clinical Trial